Form 4 Filing: Kunz Barbara Lopez Exercises Options for shares of $APVO

OPTION EXERCISE

⚡ MATERIALITY: 2/10

corporate issuer

Aptevo Therapeutics Inc.

Ticker: $APVO

Transaction Value

N/A (Non-Open-Market)

Price/Share: $0.00 (Non-Open-Market)

transaction date

2026-08-06

Shares: 400

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Kunz Barbara Lopez, holds the title of Director at Aptevo Therapeutics Inc..

On 2026-08-06, the insider transacted 400 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.

Executive Summary Summary

Kunz Barbara Lopez (Director) exercised options for $0 of $APVO

Post-Transaction Position: 400 shares

SEC Accession No: 0001193125-26-343067 (CIK: 1679970)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$APVO Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$APVO News Coverage